• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percentage of inquiries resolved via IAS Action within 10 business days of date assigned during the month

Dictionary: Globalization changed FDA’s environment for regulating products. Based on the volume of imported products, FDA identified China, India, the Middle East, Europe, and Latin America as areas in which to establish a permanent presence. These foreign posts send inquiries/requests for information to FDA headquarters. The International Affairs Staff in the Office of the Center Director is responsible for responding and/or coordinating responses with technical experts to inquiries from foreign posts concerning food and cosmetic products. This measure evaluates CFSAN's timeliness in responding to these inquiries.

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetPercentage
Oct 20118588
Nov 201185100
Dec 20118597
Jan 201285100
Feb 20128590
Mar 20128596
Apr 20128575
May 201285100
Jun 201285100
Jul 20128594
Aug 201285100
Sep 20128586

FY 2012 Overall: 95%

Number of inquiries resolved via IAS Action within 10 business days of date assigned during the month

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2011N/A28
Nov 2011N/A18
Dec 2011N/A29
Jan 2012N/A12
Feb 2012N/A9
Mar 2012N/A23
Apr 2012N/A12
May 2012N/A35
Jun 2012N/A61
Jul 2012N/A34
Aug 2012N/A32
Sep 2012N/A19

FY 2012 Total: 312

Total number of inquiries received via IAS Action during the month

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2011N/A32
Nov 2011N/A18
Dec 2011N/A30
Jan 2012N/A12
Feb 2012N/A10
Mar 2012N/A24
Apr 2012N/A16
May 2012N/A35
Jun 2012N/A61
Jul 2012N/A36
Aug 2012N/A32
Sep 2012N/A22

FY 2012 Total: 328

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.